APLLTD — Alembic Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- IN₹149.41bn
- IN₹161.55bn
- IN₹73.45bn
Brief: Alembic Pharmaceuticals Appoints G. Krishnan As CFO
Brief: Alembic Pharmaceuticals Says R. K. Baheti Relinquishes Position Of CFO
Brief: Alembic Pharmaceuticals Gets Tax Demand Of 228.3 Mln Rupees, Interest Of 103.8 Mln Rupees
Brief: Alembic Pharmaceuticals Unit Buys Utility Therapeutics
India's Alembic Pharma gains after US FDA nod for cancer drug
Brief: Alembic Pharmaceuticals Receives EIR For API-III Facility At Karakhadi
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Amlodipine And Atorvastatin Tablets
Indian pharma stocks gain after US order exempts generic drugs from price cuts
India's Zydus Life reports higher quarterly profit on new drug launches in US
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Rivaroxaban Tablets
India's Alembic Pharma's quarterly profit drops on tax expense
India's Alembic Pharmaceuticals falls after lower Q4 profit
Brief: Alembic Pharma Q4 Consol Profit 1.57 Bln Rupees
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Ticagrelor Tablets, 90 Mg
Brief: Alembic Pharmaceuticals Receives USFDA Approval For Ticagrelor Tablets
India's Alembic Pharma rises on clean chit from US FDA
Brief: Alembic Pharmaceuticals Receives EIR For Its Oncology Formulation Facility At Panelav
Indian chemical makers drop on US reciprocal tariffs
India's Alembic Pharma slides after US FDA issues observation on facility